Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Medimetriks Pharmaceuticals Inc.

Headquarters: Fairfield, NJ, United States of America
Year Founded: N/A
Status: Private

BioCentury | Jul 31, 2018
Company News

Management tracks: Canbridge, Retrophin

BioCentury | Sep 5, 2016
Clinical News

Ozenoxacin 1% regulatory update

BioCentury | Jul 11, 2016
Clinical News

Ozenoxacin 1% regulatory update

BioCentury | Feb 15, 2016
Company News

Otsuka Pharmaceutical, Medimetriks deal

BioCentury | Aug 3, 2015
Clinical News

Ozenoxacin 1%: Phase III data

BioCentury | Dec 11, 2014
Targets & Mechanisms

Lysin in wait

BioCentury | Jun 23, 2014
Clinical News

Ozenoxacin 1%: Phase III started

Items per page:
1 - 10 of 11